recombinant nematode anticoagulant protein c2
Recombinant proteinexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Dec 10, 2020 (NCT04655586)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- nematode anticoagulant protein c2Supplementation
nematode anticoagulant protein c2 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS3TTT9ZD93F ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04655586 | Phase 2/Phase 3 (Phase 3) | Dec 10, 2020 | Arca Biopharma, Inc., Colorado Prevention Center, CPC Clinical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arca Biopharma, Inc. | For profit | 1 | 1 | 1 | 2020 |
| Colorado Prevention Center | Academic/Hospital | 1 | 0 | 1 | 2020 |
| CPC Clinical Research | For profit | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1